Your browser doesn't support javascript.
loading
Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.
Kamal, Mohamed A; Lien, Kayla Yi Ting; Robson, Richard; Subramoney, Vishak; Clinch, Barry; Rayner, Craig R; Gibiansky, Leonid.
Afiliación
  • Kamal MA; Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, New York, New York, USA makamal1978@gmail.com.
  • Lien KY; Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, New York, New York, USA.
  • Robson R; Christchurch Clinical Studies Trust, Christchurch, New Zealand.
  • Subramoney V; Roche Translational and Clinical Research Center, Inc., New York, New York, USA.
  • Clinch B; Roche Products Ltd., Welwyn Garden City, United Kingdom.
  • Rayner CR; d3 Medicine LLC, Parsippany, New Jersey, USA.
  • Gibiansky L; QuantPharm LLC, North Potomac, Maryland, USA.
Antimicrob Agents Chemother ; 59(11): 6774-81, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26282419
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Diálisis Renal / Oseltamivir Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Diálisis Renal / Oseltamivir Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos